Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (411-420 of 605) with videos related to

Pageof 61
Sort By:
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
The New England Journal of Medicine|May 25, 2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, et al.
The New England Journal of Medicine|March 10, 2001
Efficacy and safety of recombinant human activated protein C for severe sepsisG R Bernard, J L Vincent, P F Laterre, et al.
JAMA|July 14, 2015
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal MalignanciesDiana W Bianchi, Darya Chudova, Amy J Sehnert, et al.
Journal of Viral Hepatitis|June 1, 2018
Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in LondonD N Aisyah, L Shallcross, A Hayward, et al.
The American Journal of Case Reports|December 28, 2020
Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid CarcinomaArezou A Ghazani, Katelyn M Breen, Meaghan Dwan, et al.
JAMA Oncology|October 28, 2021
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database AnalysisChristian P Kratz, Claire Freycon, Kara N Maxwell, et al.
Oncotarget|February 13, 2016
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al.
Breast Cancer Research and Treatment|March 7, 2012
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortSerena Masciari, Deborah A Dillon, Michelle Rath, et al.
Gynecologic Oncology|October 14, 2025
SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohortBrittany A Borden, Adela Rodriguez-Hernandez, Magan Trottier, et al.
Pageof 61

Showing results (411-420 of 605) with videos related to

Sort By:
Pageof 61
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
The New England Journal of Medicine|May 25, 2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, et al.
The New England Journal of Medicine|March 10, 2001
Efficacy and safety of recombinant human activated protein C for severe sepsisG R Bernard, J L Vincent, P F Laterre, et al.
JAMA|July 14, 2015
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal MalignanciesDiana W Bianchi, Darya Chudova, Amy J Sehnert, et al.
Journal of Viral Hepatitis|June 1, 2018
Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in LondonD N Aisyah, L Shallcross, A Hayward, et al.
The American Journal of Case Reports|December 28, 2020
Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid CarcinomaArezou A Ghazani, Katelyn M Breen, Meaghan Dwan, et al.
JAMA Oncology|October 28, 2021
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database AnalysisChristian P Kratz, Claire Freycon, Kara N Maxwell, et al.
Oncotarget|February 13, 2016
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerKyle C Strickland, Brooke E Howitt, Sachet A Shukla, et al.
Breast Cancer Research and Treatment|March 7, 2012
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortSerena Masciari, Deborah A Dillon, Michelle Rath, et al.
Gynecologic Oncology|October 14, 2025
SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohortBrittany A Borden, Adela Rodriguez-Hernandez, Magan Trottier, et al.
Pageof 61